PMID: 9420651Jun 1, 1995Paper

Impairment of cardiac function by moderate potassium depletion

Journal of Cardiac Failure
T N Srivastava, D B Young

Abstract

A previous study found that potassium depletion in dogs that resulted in a reduction in plasma potassium from 4.1 to 3.2 mmol/L was associated with impairment of many aspects of left ventricular mechanical function, including a 51% reduction in the peak rate of left ventricular filling. To determine if potassium depletion had similar effects in humans, cardiac function was assessed by Doppler and two-dimensional echocardiography in 10 normal volunteers following a 7-day period of potassium depletion, and again 7 days of potassium repletion. Potassium concentration for the group averaged 3.49 +/- 0.12 mmol/L after the depletion period, and 4.57 +/- 0.14 mmol/L after repletion. Early peak mitral flow velocity was significantly less during depletion than during repletion. The values at rest were 89.5 +/- 6.6 and 77.0 +/- 4.9 cm/s during repletion and depletion, respectively (P < .01). Isovolomic relaxation time and deceleration time of flow through the mitral valve were also significantly increased during potassium depletion. No other measured indices of cardiac function were affected by potassium depletion. The results suggest that in normal volunteers, moderate potassium depletion may impair active relaxation of the left ventric...Continue Reading

References

Jan 4, 1979·The New England Journal of Medicine·E H SonnenblickT H LeJemtel
Mar 1, 1976·Annals of Internal Medicine·W Grossman, L P McLaurin
Apr 1, 1992·Japanese Circulation Journal·K OhsatoR Takeda
May 15, 1992·The American Journal of Cardiology·P A Marcovitz, W F Armstrong
Oct 1, 1991·Journal of the American College of Cardiology·D E FitzovichD B Young
Mar 1, 1990·Progress in Cardiovascular Diseases·J C Stauffer, W H Gaasch
Apr 1, 1989·Journal of the American College of Cardiology·A L KleinA J Tajik
Jul 15, 1988·Annals of Internal Medicine·P Spirito, B J Maron
Oct 1, 1987·The American Journal of the Medical Sciences·R R Ruffolo
Jul 1, 1986·The American Journal of Cardiology·K TakenakaW L Henry
Jan 1, 1987·Journal of the American College of Cardiology·B H LeeR T Skeel
Jan 1, 1985·Progress in Cardiovascular Diseases·F S Fein, E H Sonnenblick
Apr 22, 1967·British Medical Journal
Oct 1, 1984·The American Journal of Cardiology·A H DoughertyR A Goldstein
Jan 1, 1984·Journal of Chronic Diseases·A R FrisanchoL A Bollettino
May 1, 1983·Annals of Internal Medicine·H G Langford
Apr 12, 2008·The Veterinary Clinics of North America. Small Animal Practice·Søren R Boysen

❮ Previous
Next ❯

Citations

Mar 6, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Sonal KorgaonkarRajiv Saran
May 27, 2015·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Ying-Ho LaiWen-Harn Pan
Jun 15, 2007·Kidney International·G GiebischC Wagner
Sep 2, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Marcel RoosAdnan Kastrati
Aug 12, 2008·International Journal of Cardiology·A Brent AlperAli Ahmed
Jan 22, 2011·European Journal of Clinical Investigation·Yen-Hung LinUNKNOWN TAIPAI study group
Mar 31, 2015·Heart Failure Reviews·Caterina UrsoGregorio Caimi
Jan 23, 2004·Journal of the American College of Cardiology·John E Macdonald, Allan D Struthers
Jul 22, 2011·International Journal of Cardiology·Agata Bielecka-DabrowaMaciej Banach
Aug 12, 2014·The American Journal of Medicine·Helene Kildegaard JensenAnnmarie Touborg Lassen
Jul 22, 2006·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Olga AkimovaSergei N Orlov
Oct 14, 2016·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yan YangPing-Jin Gao
Feb 9, 2017·Stroke; a Journal of Cerebral Circulation·Nick MattssonAhmad Sajadieh
Jul 5, 2006·Hypertension·David B Young
Mar 5, 2004·American Journal of Physiology. Cell Physiology·Henning Bundgaard
Jun 18, 2015·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Che-Wei LiaoUNKNOWN TAIPAI Study Group
Feb 3, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Steven G CocaGregory K Buller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.